InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.54
(
-0.19%
)
Bitcoin
65,046.56
(
0.12%
)
Post# of 145002
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

trader59

Send PM Follow Ignore
Followers 192
Posts 16567
Boards Moderated 10
Alias Born 01/29/2018

trader59

Member Level

Re: Salvatore Esposito post# 137831

Friday, 11/17/2023 12:19:00 PM

Friday, November 17, 2023 12:19:00 PM

Post# of 145002
BioAmber's interests in that patent were sold to LCYB, page 93 of the 6th monitor's report:

https://www.pwc.com/ca/en/car/bioamber/assets2/bioamber-043_120718.pdf

It was a jointly owned patent. Later on, Cargill was making the case that their development agreement with BioAmber on the jointly own patents said that they'd have sole ownership if one of them went under. One of them did, but Cargill didn't act until the court had approved the APA and the sale was closed.

It isn't unusual for a dead name to continue to be listed on patents and other documents. It is up to the new owner to get it changed.

I swear I’ll never use the phrase “you can’t make this stuff up” ever again after being on the OTC. Apparently you can.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up